Myelosuppression Monitoring After Immunomodulator Initiation in Veterans With Inflammatory Bowel Disease: A National Practice Audit

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.12075
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Association of Genetic Variants in NUDT15 With Thiopurine-Induced Myelosuppression in Patients With Inflammatory Bowel Disease

JAMA - Journal of the American Medical Association
Medicine
2019English

Therapeutic Drug Monitoring in Inflammatory Bowel Disease

Gastroenterology
HepatologyGastroenterology
2017English

An Audit of Influenza Vaccination Status in Adults With Inflammatory Bowel Disease

Canadian Journal of Gastroenterology
2012English

A Multi-Centre Audit of Excess Steroid Use in 1176 Patients With Inflammatory Bowel Disease

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Suppression of Anti-Drug Antibodies to Infliximab or Adalimumab With the Addition of an Immunomodulator in Patients With Inflammatory Bowel Disease

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Editorial: Thiopurine-Induced Myelosuppression and Infections in Inflammatory Bowel Disease Patients With a Normal TPMT Genotype-The Perils of Ageing. Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Proinflammatory Cytokines in Irritable Bowel Syndrome: A Comparison With Inflammatory Bowel Disease

Intestinal Research
Gastroenterology
2020English

Interstitial Nephritis in a Patient With Inflammatory Bowel Disease

Case Reports in Nephrology
2016English

Inflammatory Bowel Disease

Annual Review of Immunology
AllergyImmunology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy